| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | DE60125416T2 Stabilisierte formulierungen von 6-hydroxy-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-2-(4-methoxyphenyl)benzo(b)thiophen und deren salze Stabilized formulations of 6-hydroxy-3- (4- (2- (piperidin-1-yl) ethoxy) phenoxy) -2- (4-methoxyphenyl) benzo (b) thiophene and their salts |
| 09/27/2007 | CA2648829A1 Crystalline forms of n-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1h-benzimidazol-5-yl}ethanesulfonamide salts |
| 09/27/2007 | CA2643937A1 Salt of aliskiren with sulfuric acid |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1837329A1 Novel heteroaryl derivative |
| 09/26/2007 | EP1836207A2 Triazolophthalazines as pde2-inhibitors |
| 09/26/2007 | EP1836197A1 Selective muscle relaxant and pharmaceutical compositions |
| 09/26/2007 | EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 09/26/2007 | EP1836180A2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 09/26/2007 | EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/26/2007 | EP1835928A2 Mas related g protein coupled receptors as drug targets |
| 09/26/2007 | EP1835917A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 09/26/2007 | EP1835900A1 Sulfasalazine analogues as nf-kb inhibitors |
| 09/26/2007 | EP1835898A2 Methods for modulating tumor growth and metastasis |
| 09/26/2007 | EP1653948B1 Use of 5-methoxytryptamine as a cardioprotective agent |
| 09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
| 09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
| 09/26/2007 | EP1322673B1 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 09/26/2007 | EP1313481B1 Pharmaceutical composition comprising condensed indole compound |
| 09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
| 09/26/2007 | EP1265596B1 Medical emulsion for lubrication and delivery of drugs |
| 09/26/2007 | EP1261585B1 Substituted indole mannich bases |
| 09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
| 09/26/2007 | EP1194447B1 Novel potassium channels and genes encoding these potassium channels |
| 09/26/2007 | EP1140104B1 Treatment of alzheimer's disease by increasing cytidine levels in vivo |
| 09/26/2007 | CN200951201Y Medicated plaster for treating phlebitis |
| 09/26/2007 | CN101044120A Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 09/26/2007 | CN101044117A 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury |
| 09/26/2007 | CN101043916A Combination of organic compounds |
| 09/26/2007 | CN101041694A Angiogenin-like protein V and preparation method thereof, its polyclonal antibody and uses thereof |
| 09/26/2007 | CN101041683A 21-subunit digoxin derivative and preparation method thereof |
| 09/26/2007 | CN101041629A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it |
| 09/26/2007 | CN101041626A Tetrafluorobenzyl derivatives and pharmaceutical composition containing same |
| 09/26/2007 | CN101041072A The function and application of proteinase Inhibitor for protecting cardiac muscle cells |
| 09/26/2007 | CN101041060A Method for preparing encephalon glycoside and ignotin injection and the agent thereof |
| 09/26/2007 | CN101041052A Chinese traditional medicine compound took orally for treating Raynand's disease |
| 09/26/2007 | CN101041045A Capsule for treating cardiac and cerebral vascular diseases and promoting blood circulation and its preparation process |
| 09/26/2007 | CN101041031A Chinese traditional compound for treating anal fissure for external application |
| 09/26/2007 | CN101041027A External application medicine for treating hypertension |
| 09/26/2007 | CN101041022A Chinese medicinal composition for treating hemorrhoids |
| 09/26/2007 | CN101041021A Chinese medicines composition took orally for treating vrain apoplexy |
| 09/26/2007 | CN101041019A Traditional Chinese medicinal composition for treating coronary disease and its prepn. method |
| 09/26/2007 | CN101041013A Chinese traditional medicine compound took orally for treating anal fissure |
| 09/26/2007 | CN101041006A Composite Chinese medicine took orally for treating coronary heart disease |
| 09/26/2007 | CN101040997A Method for extracting leek seed total saponin and the application |
| 09/26/2007 | CN101040975A Chinese traditional medicine for creating coronary heart disease and heart angina and the preparation method |
| 09/26/2007 | CN101040970A Chinese medicine preparation for treating hypertension |
| 09/26/2007 | CN101040943A Plaster for reducing the blood pressure |
| 09/26/2007 | CN101040934A Medicine compound made of haw leaf and rhodiola |
| 09/26/2007 | CN101040907A Method of controlling the quality of salvia miltiorrhiza raw material fingerprint in the plant medicine for improving hemorheology |
| 09/26/2007 | CN101040906A Injection for treating cardiovascular or cerebrovascular disease and the preparing method and the quality control method |
| 09/26/2007 | CN101040901A Rosmarinus officinalis extract and its preparing process and application |
| 09/26/2007 | CN101040896A Flavone of astragalus extract, the medicine use and the compound thereof |
| 09/26/2007 | CN101040894A Preparing and application of Yulangsan extract |
| 09/26/2007 | CN101040886A Medicine compound of erigeron breviscapus and tanshinone IIA sodium sulfoacid |
| 09/26/2007 | CN101040885A Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin |
| 09/26/2007 | CN101040884A Method for controlling the quality of Chinese traditional medicine araloside |
| 09/26/2007 | CN101040877A Medicine function of Boshi brachytheciaceae |
| 09/26/2007 | CN101040860A Pharmaceutical composition for treatment of lower urinary tract diseases |
| 09/26/2007 | CN101040712A Compound containing DAG and the method for preparing the same |
| 09/26/2007 | CN101040687A Health-care noodle made of kudzu root |
| 09/26/2007 | CN100339706C Quality control method of injection agent for treating apoplexia |
| 09/26/2007 | CN100339379C 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-1,3-dihydoimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
| 09/26/2007 | CN100339356C Aminoadamantane derivatives as therapeutic agents |
| 09/26/2007 | CN100339132C Antithrombotic agents |
| 09/26/2007 | CN100339096C Preparation of 'Xin Ke Shu' tablet for treating coronary heart disease |
| 09/26/2007 | CN100339093C Compound medicine for treating coronary heart disease and angina pectoris and its preparing process |
| 09/26/2007 | CN100339092C Chinese medicine composition for treating apoplexy and its prepn process and use |
| 09/26/2007 | CN100339085C Combination of Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| 09/26/2007 | CN100339080C Antiviral compounds |
| 09/26/2007 | CN100339079C Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic, and medicament comprising them |
| 09/26/2007 | CN100339076C Indapamide dripping pills, and its prepn. method |
| 09/26/2007 | CN100339068C Dripping pill for treating coronary heart disease and preparing method |
| 09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
| 09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273862 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 09/25/2007 | US7273858 Salts |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273848 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273712 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 09/25/2007 | US7273466 Apparatus having a defoamer-coated surface and use of a defoamer-containing surface |
| 09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2301183C Pharmacologic drug combination in vagal-induced asystole |
| 09/25/2007 | CA2269815C Thienopyrimidines having pde v-inhibiting action |
| 09/20/2007 | WO2007106706A1 Cyclic urea compounds as soluble epoxide hydrolase inhibitors effective for the treatment of cardiovascular disorders |
| 09/20/2007 | WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | WO2007106554A2 Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds |